Literature DB >> 8526598

Predicting survival after coronary revascularization for ischemic cardiomyopathy.

S E Langenburg1, S A Buchanan, L H Blackbourne, R P Scheri, K N Sinclair, J Martinez, W D Spotnitz, C G Tribble, I L Kron.   

Abstract

BACKGROUND: The success of coronary revascularization for ischemic cardiomyopathy (left ventricular ejection fraction of 0.25 or less) has been unpredictable. We and others have demonstrated that the hospital operative mortality rate for these operations has been surprisingly low, particularly if evidence of ischemia is present. We subsequently liberalized our selection criteria based on our hypothesis that coronary artery bypass grafting is safe in this subset of patients regardless of the status of their distal coronary vasculature.
METHODS: To examine this hypothesis, we studied retrospectively our patients undergoing coronary artery bypass grafting from 1983 to 1993. Ninety-six patients with ejection fractions of 0.25 or lower underwent this operation, with 88 hospital survivors (mortality 8%). All of the patients had clinical symptoms of heart failure. The male to female ratio was 4.6:1. The average age was 63.1 +/- 0.9 years (mean +/- standard error of the mean). Patients were excluded if they had valvular heart disease other than mild to moderate mitral regurgitation, required resection of a ventricular aneurysm, or required an emergency operation for acute coronary occlusion. Possible predictors of death were examined retrospectively. The catheterization films were reviewed retrospectively by a cardiovascular surgeon who was blinded to patient outcome and was never involved in the clinical management of any of the patients. Vessel quality was described as good, fair, or poor.
RESULTS: Increased age and poor vessel quality were the only significant predictors of poor outcome. Sex, presence or absence of angina, preoperative angina, preoperative ejection fraction, preoperative arrhythmia disorder, aortic cross-clamp time, and the number of bypass grafts had no significant effect on outcome in the perioperative period.
CONCLUSION: These results demonstrate that poor vessel quality and older age are predictors of poor outcome in patients with low ejection fractions undergoing myocardial revascularization. We conclude that poor distal coronary vasculature is a contraindication to coronary artery bypass grafting in patients with an ejection fraction of 0.25 or less, even if angina is present.

Entities:  

Mesh:

Year:  1995        PMID: 8526598     DOI: 10.1016/0003-4975(95)00755-A

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Surgery for hibernation.

Authors:  J Pepper
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  Sudden cardiac death in patients with congestive heart failure: toward a unified rational treatment approach.

Authors:  D J Callans
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

3.  Relief of symptoms and improvement of quality of life five years after coronary artery bypass grafting in relation to preoperative ejection fraction.

Authors:  J Herlitz; I Wiklund; H Sjöland; B W Karlson; T Karlsson; M Haglid; M Hartford; K Caidahl
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 4.  Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction.

Authors:  F A Mitropoulos; J A Elefteriades
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

5.  Efficacy of aneurysmectomy in patients with severe left ventricular dysfunction: favorable short-and long-term results in ischemic cardiomyopathy.

Authors:  Carlos Vicente Serrano; José A F Ramires; Alexandre de Matos Soeiro; Luiz Antônio M César; Whady A Hueb; Luiz A Dallan; Fábio B Jatene; Noedir A G Stolff
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Single versus bilateral internal thoracic artery grafting in patients with low ejection fraction.

Authors:  Ariel Farkash; Dmitri Pevni; Rephael Mohr; Amir Kramer; Tomer Ziv-Baran; Yosef Paz; Nahum Nesher; Yanai Ben-Gal
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.